Advertisement
U.S. Markets closed

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.6239-0.0059 (-0.94%)
At close: 04:00PM EST
0.6051 -0.02 (-3.01%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.6298
Open0.6200
Bid0.4375 x 200
Ask0.7736 x 200
Day's Range0.5911 - 0.6300
52 Week Range0.5570 - 138.0000
Volume322,551
Avg. Volume1,249,887
Market Cap356,883
Beta (5Y Monthly)0.25
PE Ratio (TTM)N/A
EPS (TTM)-191.2700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

    TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has been awarded non-dilutive funding of $250,000 from the G-Rex® Grant Program.

  • PR Newswire

    TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

    TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today provides an update to its shareholders and highlighted the Company's operational achievements thus far in 2024.